A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Clinical trial NCT07390617 · RECRUITING
Trial details
- NCT number
- NCT07390617
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-20
- Primary completion
- 2028-01-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.